RESPONSE PENDING: Your Meeting with Tanushree Banerjee Tomorrow...
Here is the latest financial fact sheet of CAPLIN POINT. For more details, see the CAPLIN POINT quarterly results and CAPLIN POINT share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.2 |
No. of shares | m | 75.94 |
1 Week | % | 2.5 |
1 Month | % | 7.2 |
1 Year | % | 105.7 |
52 week H/L | Rs | 1,617.8/647.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
CAPLIN POINT EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 623 | 466 | 686 | 1,034 | 856 | |
Low | Rs | 305 | 180 | 264 | 407 | 575 | |
Sales per share (Unadj.) | Rs | 85.8 | 114.1 | 140.3 | 167.5 | 193.2 | |
Earnings per share (Unadj.) | Rs | 23.3 | 28.4 | 33.2 | 40.7 | 49.7 | |
Diluted earnings per share | Rs | 23.2 | 28.3 | 33.1 | 40.6 | 49.6 | |
Cash flow per share (Unadj.) | Rs | 26.4 | 32.6 | 38.1 | 46.9 | 55.6 | |
Dividends per share (Unadj.) | Rs | 2.20 | 2.50 | 3.00 | 4.00 | 4.50 | |
Adj. dividends per share | Rs | 2.19 | 2.49 | 2.99 | 3.99 | 4.50 | |
Avg Dividend yield | % | 0.5 | 0.8 | 0.6 | 0.6 | 0.6 | |
Book value per share (Unadj.) | Rs | 82.8 | 124.1 | 154.8 | 193.8 | 245.7 | |
Adj. book value per share | Rs | 82.4 | 123.6 | 154.2 | 193.4 | 245.6 | |
Shares outstanding (eoy) | m | 75.63 | 75.64 | 75.64 | 75.79 | 75.90 | |
Price / Sales ratio | x | 5.4 | 2.8 | 3.4 | 4.3 | 3.7 | |
Avg P/E ratio | x | 19.9 | 11.4 | 14.3 | 17.7 | 14.4 | |
P/CF ratio (eoy) | x | 17.5 | 9.9 | 12.5 | 15.4 | 12.9 | |
Price / Book Value ratio | x | 5.6 | 2.6 | 3.1 | 3.7 | 2.9 | |
Dividend payout | % | 9.4 | 8.8 | 9.0 | 9.8 | 9.1 | |
Avg Mkt Cap | Rs m | 35,066 | 24,433 | 35,930 | 54,593 | 54,308 | |
Total wages/salary | Rs m | 456 | 671 | 1,020 | 1,147 | 1,361 |
CAPLIN POINT INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 6,487 | 8,632 | 10,613 | 12,694 | 14,667 | |
Other income | Rs m | 190 | 413 | 279 | 389 | 565 | |
Total revenues | Rs m | 6,677 | 9,045 | 10,892 | 13,083 | 15,233 | |
Gross profit | Rs m | 2,319 | 2,601 | 3,243 | 3,945 | 4,406 | |
Depreciation | Rs m | 234 | 316 | 370 | 469 | 450 | |
Interest | Rs m | 6 | 3 | 16 | 7 | 8 | |
Profit before tax | Rs m | 2,269 | 2,695 | 3,136 | 3,858 | 4,514 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 503 | 544 | 622 | 774 | 744 | |
Profit after tax | Rs m | 1,766 | 2,151 | 2,514 | 3,085 | 3,770 | |
Gross profit margin | % | 35.7 | 30.1 | 30.6 | 31.1 | 30.0 | |
Effective tax rate | % | 22.2 | 20.2 | 19.8 | 20.1 | 16.5 | |
Net profit margin | % | 27.2 | 24.9 | 23.7 | 24.3 | 25.7 |
CAPLIN POINT BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 4,937 | 8,225 | 10,146 | 12,978 | 15,545 | |
Current liabilities | Rs m | 861 | 1,443 | 1,429 | 2,077 | 2,680 | |
Net working cap to sales | % | 62.8 | 78.6 | 82.1 | 85.9 | 87.7 | |
Current ratio | x | 5.7 | 5.7 | 7.1 | 6.2 | 5.8 | |
Inventory Days | Days | 46 | 30 | 14 | 52 | 70 | |
Debtors Days | Days | 899 | 968 | 10 | 9 | 10 | |
Net fixed assets | Rs m | 2,488 | 3,032 | 3,490 | 4,323 | 6,231 | |
Share capital | Rs m | 510 | 897 | 897 | 897 | 898 | |
"Free" reserves | Rs m | 5,750 | 8,488 | 10,813 | 13,787 | 17,754 | |
Net worth | Rs m | 6,261 | 9,385 | 11,710 | 14,685 | 18,651 | |
Long term debt | Rs m | 3 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 7,425 | 11,258 | 13,636 | 17,301 | 21,776 | |
Interest coverage | x | 391.5 | 843.1 | 198.2 | 552.2 | 579.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.8 | 0.8 | 0.7 | 0.7 | |
Return on assets | % | 23.9 | 19.1 | 18.6 | 17.9 | 17.3 | |
Return on equity | % | 28.2 | 22.9 | 21.5 | 21.0 | 20.2 | |
Return on capital | % | 36.3 | 28.7 | 26.9 | 26.3 | 24.2 | |
Exports to sales | % | 78.4 | 57.2 | 44.4 | 39.1 | 32.8 | |
Imports to sales | % | 11.8 | 8.0 | 3.1 | 2.5 | 1.7 | |
Exports (fob) | Rs m | 5,087 | 4,941 | 4,713 | 4,966 | 4,804 | |
Imports (cif) | Rs m | 768 | 687 | 333 | 312 | 243 | |
Fx inflow | Rs m | 5,087 | 4,941 | 4,713 | 4,966 | 4,804 | |
Fx outflow | Rs m | 964 | 807 | 333 | 312 | 243 | |
Net fx | Rs m | 4,123 | 4,134 | 4,379 | 4,654 | 4,561 |
CAPLIN POINT CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 834 | 447 | 2,686 | 3,367 | 2,714 | |
From Investments | Rs m | -1,005 | -545 | -294 | -3,768 | -2,176 | |
From Financial Activity | Rs m | 898 | 798 | -240 | -407 | -282 | |
Net Cashflow | Rs m | 735 | 701 | 2,150 | -808 | 268 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: C C Paarthipan | COMP SEC: Dinesh RG | YEAR OF INC: 1990 | BSE CODE: 524742 | FV (Rs): 2 | DIV YIELD (%): 0.3 |
Read: CAPLIN POINT 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare CAPLIN POINT With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.